Clinical Trial Update: A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) [Phase 1, Phase 2]

View source ↗

Summary

Update on the RESOLUTE gene transfer study for late-onset Pompe disease, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Snippet

Sponsor: Spark Therapeutics, Inc. | Conditions: Pompe Disease, Pompe Disease (Late-onset) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING